Abstract
Nanostructures have shown immense potential in improving drug absorption and bioavailability, particularly for poorly soluble compounds that face challenges in conventional drug delivery systems. These nanostructures, including nanoparticles, nanocrystals, and lipid-based nanocarriers, can enhance drug solubility, increase surface area for absorption, and protect drugs from degradation. Additionally, they can be tailored to target specific sites in the body, thereby reducing side effects and improving therapeutic efficacy. This article discusses the types of nanostructures commonly used in drug delivery, their mechanisms of enhancing absorption, and their application in improving bioavailability. The challenges in scaling these technologies for clinical use and their potential future directions are also explored.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Dr. Maria L. Fernandez (Author)